ONC Latest Headlines

BeOne Medicines Targets CLL Leaders With New Phase 3 Head-to-Head Trial

at www.tipranks.com (Thu, 15-Jan 11:32 AM)

Citi Sticks to Their Buy Rating for BeOne Medicines (ONC)

at www.tipranks.com (Thu, 15-Jan 6:36 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: BeOne Medicines (ONC), United Therapeutics (UTHR) and Moderna (MRNA)

at www.tipranks.com (Mon, 12-Jan 9:50 PM)

Phase 3 HERIZON-GEA-01 Results Position ZIIHERA Plus TEVIMBRA and Chemotherapy as Potential New Standard for HER2+ Advanced GEA

Market Chameleon (Wed, 7-Jan 9:03 AM)

BeOne Medicines to Spotlight Global Oncology Advances at 44th J.P. Morgan Healthcare Conference

Market Chameleon (Tue, 23-Dec 8:56 AM)

ZIIHERA-Based Regimens Set to Redefine First-Line HER2-Positive Gastric Cancer Treatment

Market Chameleon (Mon, 17-Nov 9:02 AM)

ONC Delivers 41% Revenue Growth, Brukinsa Takes BTKi Lead, and Free Cash Flow Hits Record Highs in Q3 2025

Market Chameleon (Thu, 6-Nov 8:47 AM)